维普期刊资源整合服务平台（V6.5）

87篇 您的检索式：作者名="Diasio"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Dihydropyrimidine dehydrogenase activity and fluorouracil chemotherapy显示文摘	Diasio RB Lu Z	1994	J Clin Oncol1994，12，11：	1
2	Dihydropyrimidine dehydrogenase deficiency in an Indian population显示文摘	Muhammad Wasif Saif Lori Mattison Tom Carollo Hany Ezzeldin Robert B. Diasio	2006	Cancer Chemotherapy and Pharmacology2006，，3：	1
3	Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics显示文摘	Mattison LK Soong R Diasio RB	2002	Pharmacogenomics2002，3，4：	1
4	A retrospective study of coagulation abnormalities in patients receiving concomitant capecitabine and warfarin 显示文摘	Shah H R Ledbetter L Diasio R	2006	Clin Colorectal Cancer2006，5，5：	1
5	Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics显示文摘	Mattison L K Soong R Diasio R B	2002	Pharmacogenomics2002，3，4：	1
6	Histone deacetylase inhibitors: current status and overview of recent clinical trials显示文摘	Ma X Ezzeldin HH Diasio RB	2009	Drugs2009，69，：	1
7	Alternative schedules with irinotecan显示文摘	Diasio R	2003	Semin in Oncol2003，30，4：	1
8	Hand-foot syndrome variant in a dihydropyrimidine dehydrogenase-deficient patient treated with capecitabine显示文摘	Saif M W Elfiky A Diasio R	2006	Clin Colorectal Cancer2006，6，3：	1
9	Comparative pharma- cokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluraeil in patients with advanced solid tumors 显示文摘	ADJEI A A REID J M DIASIO R B	2002	J Clin Oncol2002，20，6：	1
10	Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer 显示文摘	MEROPOL N J GOLD P J DIASIO R B	2006	J Clin Oncol2006，24，25：	1
11	Thymidine phos- phorylase expression is associated with response to eapecitabineplus irinotecan in patients with metastatic colorectal cancer显示文摘	MEROPOL N J GOLD P J DIASIO R B	2006	J Clin Oncol2006，24，25：	1
12	Dihydorpyrimidine deydorgenase activity and fluorouracil chemotherapy 显示文摘	Diasio RB Lu Z	1994	J Clin Oncol1994，12，11：	1
13	Hand-foot syndrome variant in a dihydropyrimidine dehydrogenase-deficient patient treated with capecitabine显示文摘	Saif M W Elfiky A Diasio R	2006	Clin Colorectal Cancer2006，6，3：	1
14	Histone deacetylase inhibitors: current status and overview of recent clinical trials 显示文摘	MA X EZZELDIN H H DIASIO R B	2009	Drugs2009，69，14：	1
15	Hand-foot syndrome variant in a dihydropyrimidine dehydrogenase-deficient patient treated with capecitabine显示文摘	Saif MW Elfiky A Diasio R	2006	Clin Colorectal Cancer2006，6，3：	1
16	Edotecarin: a novel topoisomerase I inhibitor显示文摘	SAIF MW DIASIO RB	2005	Clin Colorectal Cancer2005，5，1：	1
17	Melabolism of pyrimidine ana- logues and their nueleosides显示文摘	Daher GC Harris BE Diasio RB	1990	Pharmacol Ther1990，48，2：	1
18	Capecitabine induces rapid, sustained response in two patients with extensive oral verrueous carcinoma显示文摘	Salesiotis A Soong R Diasio RB	2003	Clin Cancer Res2003，9，2：	1
19	Adenocarcinoma of the pancreas associated with hypoglycemia:case report and review of the literature显示文摘	Diasio RB Eanes RZ Chen ML		0，，：	1
20	Histone deacetylase inhibitors: current status and overview of recent clinical trials 显示文摘	Ma X Ezzeldin HH Diasio RB	2009	Drugs2009，69，14：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示